Aaron Wukmir

Brooks O'Neil

Anderson Schock

- Electromed reported **record financial results** for the fiscal fourth quarter and full year 2025, with Q4 revenue increasing **17.3%** year-over-year to **$17.4 million** and diluted earnings per share rising to **$0.25**.  **[1488917_d55494c2338f4ef5a8c8d8c332413c6b]** 
- The company achieved **eleven consecutive quarters** of year-over-year revenue and operating income growth, driven by strong performance in its Direct Homecare business and improved gross margin.  **[1488917_d55494c2338f4ef5a8c8d8c332413c6b]** 
- Following the earnings announcement, Electromed's stock price **rose 10%** to **$22.80** in after-hours trading.  **[1488917_d55494c2338f4ef5a8c8d8c332413c6b]** 
- During fiscal 2025, Electromed repurchased shares of its common stock and initiated a manufacturing optimization plan expected to complete in fiscal 2026.  **[1488917_d55494c2338f4ef5a8c8d8c332413c6b]**

Electromed (ELMD)